How to Study Schedule I Controlled Substances

  Q:  I want to study schedule I controlled substances. I want to study marijuana (cannabis), peyote, MDMA, psilocybin, LSD, ayahuasca/DMT and ibogaine, to start. A:  All of that is possible, but you should choose just one. Q:  OK, I want to study cannabis. A:  That’s actually one of the hardest. Please choose a better […]

The post How to Study Schedule I Controlled Substances appeared first on Harris Bricken.

Read more

How These Two Pot Stocks Could Provide an Accessible Entrance Into the…

The post These “Cheap” Marijuana Stocks are All the Rage Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more

How These Two Pot Stocks Could Show Upward Momentum In the past…

The post Marijuana Stocks Are Showing Potential In a Down Economy  appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more

1933 Industries Announces $5 Million Private Placement 1933 Industries Inc. (the “Company”…

The post 1933 Industries Inc. (TGIFF) Announces $5 Million Private Placement appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more

How Will These Factors Affect Pot Stocks and the Cannabis Industry Moving…

The post The Biggest Factors That Marijuana Stocks Are Facing Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Indiana Smokable Hemp Ban is Upheld (For Now)

The Agriculture Improvement Act of 2018 (“2018 Farm Bill”) legalized hemp by removing hemp and its derivatives from the definition of marijuana under the Controlled Substances Act (“CSA”). The 2018 Farm Bill also provided a detailed framework for the production of hemp and directed the U.S. Department of Agriculture (“USDA”) to promulgate regulations and permitted […]

The post Indiana Smokable Hemp Ban is Upheld (For Now) appeared first on Harris Bricken.

Read more

A 2018 report estimates that mental health issues could cost the global economy $16 trillion between now and 2030. Psychedelic drugs are needed to mitigate those costs.

Read more
Champignon Provides Corporate Update

2020-07-13 PSW Editor Psychedelic Stock Watch

Read more
Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc

This release confirms Mydecine’s June 10th announcement of the acquisition of NeuroPharm Inc.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )